Emergency contraception

Cadence OTC Promotes Confidence This Valentine’s Day with Advance Planning for Those Unplanned Moments

Retrieved on: 
Thursday, February 8, 2024

With Valentine's Day approaching, a day filled with romance and love, Cadence OTC reminds individuals and couples to embrace confidence and preparedness for intimate moments.

Key Points: 
  • With Valentine's Day approaching, a day filled with romance and love, Cadence OTC reminds individuals and couples to embrace confidence and preparedness for intimate moments.
  • Understanding that even the best-laid plans can go awry, Cadence OTC advocates stocking up on Morning After Pill for those unexpected emergencies.
  • "Valentine's Day celebrates love, and in honoring that bond, we think it's essential to be ready for anything," states Samantha Miller, Co-CEO of Cadence OTC.
  • This Valentine's Day, Cadence OTC invites you to celebrate love with confidence and peace of mind, knowing you are prepared for the unexpected.

Cadence OTC Offers a Holiday Back-Up Plan with Online Availability of Morning After Pill for OOPS-Free Romantic New Year's Weekend

Retrieved on: 
Thursday, December 14, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231214488969/en/
    Cadence OTC Offers a Holiday Back-Up Plan with Online Availability of Morning After Pill for OOPS-Free Romantic New Year's Weekend (Photo: Business Wire)
    "The joy of the holiday season can mean spontaneous and sometimes unprotected sex for many couples,” says Samantha Miller, co-founder, and CEO of Cadence OTC.
  • “With the aim of preventing unintended pregnancies, Cadence OTC is thrilled to make our Morning After Pill available online just in time for that romantic New year’s weekend.
  • Protection Oversight: In the whirlwind of holiday festivities, if protection is forgotten, Cadence OTC’s Morning After pill ensures that a back-up plan is just a click away.
  • To ensure a worry-free New Year's weekend, learn more and stock up on Cadence OTC's Morning After Pill by visiting https://cadenceotc.com/products/morning-after-pill .

Lil’ Drug Store Products, Inc. Becomes Exclusive Convenience Channel Distributor for Cadence OTC’s Morning After Pill™, Expanding Access & Affordability of Emergency Contraception in Contraceptive Deserts

Retrieved on: 
Wednesday, October 4, 2023

Lil’ Drug Store Products, Inc. (LDSP) , a trusted supplier of health and beauty care (HBC) and general merchandise across convenience, travel, and hospitality retailers announces its exclusive distribution partnership with Cadence OTC ’s emergency contraceptive (EC) product, Morning After Pill™.

Key Points: 
  • Lil’ Drug Store Products, Inc. (LDSP) , a trusted supplier of health and beauty care (HBC) and general merchandise across convenience, travel, and hospitality retailers announces its exclusive distribution partnership with Cadence OTC ’s emergency contraceptive (EC) product, Morning After Pill™.
  • View the full release here: https://www.businesswire.com/news/home/20231004860598/en/
    Lil' Drug Store Products, Inc. expands access and affordability of emergency contraception in partnership with Cadence OTC for the launch of Morning After Pill™.
  • Despite this escalating consumer demand, significant distribution gaps persist, preventing consumers from accessing EC options where and when they need them.
  • Through this partnership with Cadence OTC, LDSP is eliminating obstacles that have historically hindered women’s access to ECs, including cost, prescription requirements and limited availability.

Nurx Launches Urgent Care, Starting with Overnight Delivery of Emergency Contraception

Retrieved on: 
Tuesday, July 20, 2021

By meeting the demand for urgent emergency contraception through access to medical providers 7 days a week and overnight shipping, Nurx is breaking down barriers to sensitive health needs and offering comprehensive care," said Varsha Rao, CEO of Nurx.

Key Points: 
  • By meeting the demand for urgent emergency contraception through access to medical providers 7 days a week and overnight shipping, Nurx is breaking down barriers to sensitive health needs and offering comprehensive care," said Varsha Rao, CEO of Nurx.
  • "Our patients who trust Nurx with their ongoing medical needs are also seeking urgent solutions and Nurx Now will provide that, first in emergency contraception with other urgent care options to follow."
  • Nurx has already prescribed emergency contraception to more than 60,000 patients but with Nurx Now, patients will be able to get their urgently needed emergency contraception delivered directly to their door with expedited shipping.
  • "By offering emergency contraception with expedited shipping, Nurx makes this valuable pregnancy prevention tool more accessible and continues our commitment to destigmatizing personal health needs."

U.S. FDA Approves NEXTSTELLIS®, New Oral Contraceptive

Retrieved on: 
Friday, April 16, 2021

"\nNearly 10 million American women use short-acting combination contraceptives (estrogen and progestin).

Key Points: 
  • "\nNearly 10 million American women use short-acting combination contraceptives (estrogen and progestin).
  • It has more selective activity in tissues, focusing on those needed to support contraceptive efficacy, cycle control and other beneficial effects of estrogen.
  • According to phase 3 study findings, NEXTSTELLIS demonstrated contraceptive efficacy across all subgroups by age, BMI1 and prior hormonal contraception use.
  • The company has an extensive Women\'s Health portfolio focused on contraceptives, including its flagship birth control product, NEXTSTELLIS.

DKT International Navigates "New Normal" Providing Access to Contraception In 90 Countries to Help Avoid Unintended Pregnancies and HIV/STIs

Retrieved on: 
Tuesday, September 22, 2020

The lockdowns that governments instituted to slow the spread of the virus have impeded access to modern contraception, says Chris Purdy, CEO of DKT.

Key Points: 
  • The lockdowns that governments instituted to slow the spread of the virus have impeded access to modern contraception, says Chris Purdy, CEO of DKT.
  • The below updates from DKT offer a glimpse into the work being done to help people protect their sexual and reproductive health:
    Providing more options to customize need.
  • DKT launched male and female condoms in Colombia, female condoms and IUDs in Paraguay, IUDs in Ecuador, and emergency contraception in Bolivia.
  • DKT WomanCare recently announced its partnership with Incepta Pharmaceuticals to expand access to a 3-month injectable contraceptive in 40 countries around the world.

DGAP-News: National Comprehensive Cancer Network(R) Adds Monjuvi(R) (tafasitamab-cxix) to its Clinical Practice Guidelines in Oncology for B-cell Lymphomas

Retrieved on: 
Tuesday, August 18, 2020

o You should use an effective method of birth control (contraception) during treatment and for at least 3 months after your final dose of MONJUVI.

Key Points: 
  • o You should use an effective method of birth control (contraception) during treatment and for at least 3 months after your final dose of MONJUVI.
  • o Tell your healthcare provider right away if you become pregnant or think that you may be pregnant during treatment with MONJUVI.
  • You should also read the lenalidomide Medication Guide for important information about pregnancy, contraception, and blood and sperm donation.
  • Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Nurx Honors World Contraception Day by Donating Birth Control to Women in Need

Retrieved on: 
Thursday, September 26, 2019

They will provide 1,000 low-income women with a one-year supply of birth control at no cost.

Key Points: 
  • They will provide 1,000 low-income women with a one-year supply of birth control at no cost.
  • The purpose of World Contraception Day is to expand awareness about contraception options and empower people to make informed decisions about their reproductive health.
  • Nurx offers over 100 types of birth control, including the pill, patch, ring, and shot, as well as emergency contraception.
  • Patients who are interested in obtaining a birth control prescription through Nurx are asked to complete a dynamic health survey through the Nurx app.

Global Contraceptive Pills (Progestin & Combination) Market, Competition, Forecast & Opportunities, 2024 - ResearchAndMarkets.com

Retrieved on: 
Monday, August 26, 2019

The "Global Contraceptive Pills Market By Pill Type (Progestin Pills & Combination Pills), By Category (Generic & Branded), By Sales Channel, By Region (North America, Europe, APAC, South America & MEA), Competition, Forecast & Opportunities, 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Contraceptive Pills Market By Pill Type (Progestin Pills & Combination Pills), By Category (Generic & Branded), By Sales Channel, By Region (North America, Europe, APAC, South America & MEA), Competition, Forecast & Opportunities, 2024" report has been added to ResearchAndMarkets.com's offering.
  • However, factors like time constraints associated with the intake of emergency contraceptive pills and their side-effects, are expected to hamper the sales of emergency contraceptive pills during forecast period.
  • Regionally, North America accounted for a significant share of around 40% of the global contraceptive pills market in 2018.
  • Among countries, the US contraceptive pills market accounted for majority share in the North American contraceptive pills market in 2018 and is anticipated to maintain its dominance during forecast period as well.

Global Contraceptive Pills Markets 2013-2018, 2019-2024

Retrieved on: 
Friday, August 23, 2019

However, factors like time constraints associated with the intake of emergency contraceptive pills and their side-effects, are expected to hamper the sales of emergency contraceptive pills during forecast period.

Key Points: 
  • However, factors like time constraints associated with the intake of emergency contraceptive pills and their side-effects, are expected to hamper the sales of emergency contraceptive pills during forecast period.
  • In terms of category, the contraceptive pills market is segmented into generic and branded, of which branded drug category accounted for a significant share in the global contraceptive pills market in 2018 and the segment is anticipated to maintain its dominance during forecast period as well.
  • Regionally, North America accounted for a significant share of around 40% of the global contraceptive pills market in 2018.
  • Among countries, the US contraceptive pills market accounted for majority share in the North American contraceptive pills market in 2018 and is anticipated to maintain its dominance during forecast period as well.